ABT catalyst calendar
Clinical trials led by listed companies, by the completion date the sponsor registered on ClinicalTrials.gov, soonest first, from today. Most future dates are the sponsor's estimate and can move.
- Completion LockedNo phase registeredNCT06888687Comparison of Dietetics Support With and Without Continuous Glucose Monitoring in Individuals With Type 2 Diabetes.Australian Catholic University · Type 2 Diabetes Mellitus (T2DM)Active, not recruitingABTCollaborator
- Enrollment
- Locked
- Primary completion
- Nov 28, 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedNo phase registeredNCT05434650Abbott Atrial Fibrillation Post Approval StudyAbbott Medical Devices · Atrial ArrhythmiaActive, not recruitingABTLead
- Enrollment
- Locked
- Primary completion
- Oct 22, 2024Actual
- Interventions
- Locked
- Completion LockedNo phase registeredNCT02000115Portico Re-sheathable Transcatheter Aortic Valve System US IDE TrialAbbott Medical Devices · Aortic Valve StenosisActive, not recruitingABTLead
- Enrollment
- Locked
- Primary completion
- Oct 2019Actual
- Interventions
- Locked
- Completion LockedNo phase registeredNCT05073419Arrhythmia Detection After MISamir Saba · Acute Myocardial InfarctionRecruitingABTCollaborator
- Enrollment
- Locked
- Primary completion
- Dec 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedNo phase registeredNCT06669637Amplify EP RegistryHeart Rhythm Clinical and Research Solutions, LLC · Atrial FibrillationNot yet recruitingABTCollaborator
- Enrollment
- Locked
- Primary completion
- May 31, 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedNo phase registeredNCT06899776Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency DepartmentWake Forest University Health Sciences · ACS (Acute Coronary Syndrome)Active, not recruitingABTCollaborator
- Enrollment
- Locked
- Primary completion
- Sep 15, 2025Actual
- Interventions
- Locked
- Completion LockedNo phase registeredNCT06921902Glycemic Metrics and Patterns in People With and Without PrediabetesAbbott Diabetes Care · Pre DiabetesRecruitingABTLead
- Enrollment
- Locked
- Primary completion
- Dec 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedNo phase registeredNCT07271043Nutrition+: Effect of a High-Protein Diabetes Formula on Body Composition in Type 2 Diabetes Patients Treated With Incretin MimeticsJoslin Diabetes Center · Type 2 DiabetesRecruitingABTCollaborator
- Enrollment
- Locked
- Primary completion
- Nov 1, 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedNo phase registeredNCT04489823PARADIGM: Amplatzer Valvular Plug for PVL ClosureAbbott Medical Devices · Paravalvular Aortic RegurgitationActive, not recruitingABTLead
- Enrollment
- Locked
- Primary completion
- Nov 20, 2025Actual
- Interventions
- Locked
- Completion LockedNo phase registeredNCT04641416Noninvasive Cardiovascular Diagnosis of Patients With Fully Magnetically Levitated Blood PumpsThomas Schlöglhofer, PhD, MSc · End-stage Heart FailureRecruitingABTCollaborator
- Enrollment
- Locked
- Primary completion
- Dec 15, 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedNo phase registeredNCT04959552FSL2 Post Approval Study for Pediatric and Young Adults PatientsAbbott Diabetes Care · Diabete MellitusActive, not recruitingABTLead
- Enrollment
- Locked
- Primary completion
- Dec 30, 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedNo phase registeredNCT06039176Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the FutureInternational Consortium of Circulatory Assist Clinicians · LVADRecruitingABTCollaborator
- Enrollment
- Locked
- Primary completion
- Dec 30, 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedNo phase registeredNCT05333068COMBINE-INTERVENE: COMBINEd Ischemia and Vulnerable Plaque Percutaneous INTERVENtion to Reduce Cardiovascular EventsDiagram B.V. · Multivessel Coronary Artery DiseaseActive, not recruitingABTCollaborator
- Enrollment
- Locked
- Primary completion
- Sep 16, 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedNo phase registeredNCT05655910Enhanced Nutritional Optimization in LVAD TrialColumbia University · Heart FailureRecruitingABTCollaborator
- Enrollment
- Locked
- Primary completion
- Oct 2026Sponsor estimate
- Interventions
- Locked
- Completion LockedNo phase registeredNCT06106594VOLT CE Mark StudyAbbott Medical Devices · Atrial ArrhythmiaActive, not recruitingABTLead
- Enrollment
- Locked
- Primary completion
- Jan 2027Sponsor estimate
- Interventions
- Locked
- Completion LockedNo phase registeredNCT07599982Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With DiabetesDreaMed Diabetes · Type 1 Diabetes (T1D)RecruitingABTCollaborator
- Enrollment
- Locked
- Primary completion
- Jan 2027Sponsor estimate
- Interventions
- Locked
- Completion LockedNo phase registeredNCT07215104A Prospective Evaluation of Spinal Cord Induced Muscle Stimulation (MuscleSCS) for the Treatment of Chronic Low Back PainWVU Medicine Thomas Hospitals · Chronic Low Back Pain (CLBP)RecruitingABTCollaborator
- Enrollment
- Locked
- Primary completion
- Oct 7, 2026Sponsor estimate
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 17 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerHow to read this calendar
Completion dates as registered on ClinicalTrials.gov by the sponsor, for trials Signal8 links to a listed company. Most future dates are the sponsor's estimate and move. A completion date is when the last participant is measured, not when results are announced.
The window starts today. A date the sponsor registered to the day is listed when it falls inside the window; a date that has already passed is never listed as upcoming, even when the sponsor has not updated it yet. A date registered to the month only (shown as, say, Dec 2026) could be any day of that month, so it is listed only when the whole month falls inside the window. TrialScanner never adds a day the sponsor did not register.
By default the list shows trials where a listed company is the lead sponsor. Trials a listed company only collaborates on (as a partner, drug supplier or contract research organization) are added with the role filter, and every company is labelled Lead or Collaborator.
Free readers see the first 25 trials of any filter and windows up to 90 days, with the trial, phase, status, sponsor and primary completion. Enrollment, interventions, the start and completion dates, longer windows and later pages are part of the plan. See the methodology.